REGULATION OF FIBRINOLYSIS AT SITES OF ARTERIAL INJURY
REGULATION OF FIBRINOLYSIS AT SITES OF ARTERIAL INJURY
批准号:
6504160
负责人:
William P Fay
金额:
$13.59万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-01 至 2003-08-31
关键词:
antifibrinolytic agents apolipoproteins cardiovascular pharmacology carotid artery clearance rate coagulation factor V disease /disorder model fibrinolysis genetically modified animals human tissue injury laboratory mouse model design /development pathologic process plasminogen activator inhibitors thrombosis vitronectin
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Fibrin deposition in response to vascular injury is a key factor in the
pathogenesis of acute and chronic arterial diseases. The fibrinolytic
system constitutes a critical response mechanism to intravascular fibrin
formation and plays a major role in determining the out come of
arterial injury. The overall goal of this application is to define
mechanisms that regulate fibrinolysis within the environment of the
injured artery. In preliminary studies, we have devised a murine
carotid injury model to PAI-1-deficient mice and demonstrated that
these animals exhibit enhanced clearance of platelet-rich arterial
thrombi. We also hypothesize that binding of plasminogen to arterial
thrombi is a major determinant of their clearance, and that factor V
and apolipoprotein (a) retard arterial fibrinolysis by inhibiting
plasminogen recruitment to sites of arterial injury. To test these
hypotheses, we will apply our carotid injury model to transgenic mice
that a) lack or overexpress PAI- 1, b) exhibit tissue-specific expression
of factor V or express a factor V mutant that is resistant to inactivation
by activated protein C, or c) express human apolipoprotein (a). This
project has four Specific Aims. Specific Aim 1 is to study the effects
of variable and tissue-specific PAI-1 expression on the clearance of
acute arterial thrombi in mice. Specific Aim 2 is to determine if
apolipoprotein (a) inhibits recruitment of plasminogen to acute arterial
thrombi and to determine if platelet factor V contributes to the
inhibition of fibrinolysis by platelets. SpecificAim 3 is to examine the
time course and cellular characteristics of neointima formation in
murine carotid arteries after FeC13 injury and to study the effects of
apolipoprotein (a) on neointima formation. Specific Aim 4 is to
generate mice transgenic for human plasminogen and to use these
animals to probe mechanisms that inhibit the function of exogenous
plasminogen activators. The preliminary data outlined in this
application as well as the interactive nature of this program project
Grant application strongly support the feasibility of these objective.
We anticipate that the information gained from these studies will
greatly enhance our understanding of mechanisms that regulate fibrin
clearance at sites of arterial injury and better define the role of the
fibrinolytic system in the pathogenesis of acute and chronic arterial
disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence
-
批准号:10512042
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:William P Fay
-
依托单位:
Role of Plasminogen Activator Inhibitor-1 in Vascular Smooth Muscle Cell Stiffening and Senescence
-
批准号:10259921
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2021
-
负责人:William P Fay
-
依托单位:
Midwest Biomedical Accelerator Consortium: MBArC
-
批准号:10312631
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2020
-
负责人:William P Fay
-
依托单位:
Midwest Biomedical Accelerator Consortium: MBArC
-
批准号:10230468
-
项目类别:
-
资助金额:$117.16万
-
财政年份:2020
-
负责人:William P Fay
-
依托单位:
Midwest Biomedical Accelerator Consortium: MBArC
-
批准号:10475264
-
项目类别:
-
资助金额:$98.1万
-
财政年份:2019
-
负责人:William P Fay
-
依托单位:
Midwest Biomedical Accelerator Consortium: MBArC
-
批准号:10240635
-
项目类别:
-
资助金额:$98.1万
-
财政年份:2019
-
负责人:William P Fay
-
依托单位:
Midwest Biomedical Accelerator Consortium: MBArC
-
批准号:10022343
-
项目类别:
-
资助金额:$98.1万
-
财政年份:2019
-
负责人:William P Fay
-
依托单位:
Midwest Biomedical Accelerator Consortium: MBArC
-
批准号:10730211
-
项目类别:
-
资助金额:$12.39万
-
财政年份:2019
-
负责人:William P Fay
-
依托单位:
Midwest Biomedical Accelerator Consortium: MBArC
-
批准号:9897387
-
项目类别:
-
资助金额:$99.47万
-
财政年份:2019
-
负责人:William P Fay
-
依托单位:
Role of Plasminogen Activator Inhibitor-1 in Adipose Tissue Dysfunction and Atherosclerosis in Metabolic Syndrome
-
批准号:9913573
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2018
-
负责人:William P Fay
-
依托单位:
Role of Plasminogen Activator Inhibitor-1 in Adipose Tissue Dysfunction and Atherosclerosis in Metabolic Syndrome
-
批准号:10155514
-
项目类别:
-
资助金额:$36.02万
-
财政年份:2018
-
负责人:William P Fay
-
依托单位:
Role of Fibrinolytic System in Vein Graft Remodeling
-
批准号:8624509
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:William P Fay
-
依托单位:
Role of Fibrinolytic System in Vein Graft Remodeling
-
批准号:8774154
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:William P Fay
-
依托单位:
Role of Fibrinolytic System in Vein Graft Remodeling
-
批准号:8443294
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:William P Fay
-
依托单位:
Role of Fibrinolytic System in Vein Graft Remodeling
-
批准号:8971943
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:William P Fay
-
依托单位:
PAI-1 and Vitronectin in Failure of Coronary Revascularization
-
批准号:8305526
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2010
-
负责人:William P Fay
-
依托单位:
PAI-1 and Vitronectin in Failure of Coronary Revascularization
-
批准号:8518443
-
项目类别:
-
资助金额:$35.11万
-
财政年份:2010
-
负责人:William P Fay
-
依托单位:
Roles of Plasminogen Activator Inhibitor-1 and Vitronectin in Failure of Coronary
-
批准号:8120960
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2010
-
负责人:William P Fay
-
依托单位:
Roles of Plasminogen Activator Inhibitor-1 and Vitronectin in Failure of Coronary
-
批准号:7987377
-
项目类别:
-
资助金额:$38.47万
-
财政年份:2010
-
负责人:William P Fay
-
依托单位:
Regulation of Fibrinolysis at Sites of Arterial Injury
-
批准号:6998837
-
项目类别:
-
资助金额:$38.33万
-
财政年份:2004
-
负责人:William P Fay
-
依托单位:
海外基金